Events
-
-
-
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
SAVETHEBOTTOMS!!! Community-based anal cancer screening shows promise for MSM and transgender women
A recent JAMA Surgery study by Welton et al. evaluated the feasibility and acceptability of…
Alcohol and cancer: what clinicians need to know
A recent JAMA Insights article by Morford et al. highlights the strong link between alcohol…
A single genetic mutation may have made humans more vulnerable to cancer than chimpanzees
New research from the UC Davis Comprehensive Cancer Center, USA, has uncovered an evolutionary change…
ASCO 2025: Trastuzumab deruxtecan can help some people with advanced gastric cancers live about 3 months longer
- ASCO 2025: Exercise programme may lower risk of recurrence and death for some colon cancer survivors
- ASCO 2025: Perioperative treatment with durvalumab and FLOT chemo can reduce risk of recurrence for some gastric cancers
- ASCO 2025: Zanidatamab plus chemotherapy shows strong first-line efficacy in HER2-positive gastro-oesophageal adenocarcinoma
The OJC Meets Dorothy Keefe
The Oncology Podcast, brought to you by oncologynews.com.au, is proud to present the latest episode in our ‘The OJC Meets…’…
Combination treatment improves response to immunotherapy for lung cancer
- TGF-beta and RAS signaling are both required for lung cancer metastasis, study finds
- WCLC 2024: NeoCOAST-2 Data shows combination of Durvalumab with novel agents increases pathological responses in resectable NSCLC — Data builds on AEGEAN study research
- WCLC 2024: NeoCOAST-2 Data shows combination of durvalumab with novel agents increases pathological responses in resectable NSCLC
It’s a myth that sunscreen prevents melanoma in people of colour: A dermatologist explains
Adewole S. Adamson, University of Texas at Austin Melanoma is a potentially deadly form of skin cancer that effects people…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.